Research Assistant University of Helsinki Helsinki, Uusimaa, Finland
Introduction: Atherosclerosis is a leading cause of mortality, with current therapies inadequately addressing residual cardiovascular risks. HDL-mediated reverse cholesterol transport is a promising target, yet therapies increasing HDL-C often fail clinically. This highlights the need for innovative synthetic HDL (sHDL) nanoparticles, incorporating phospholipids and apoA-I mimetic peptides like 22A. While the peptide is well-characterized, the impact of lipid composition on s-HDL properties and remodeling efficacy remains less understood.
Learning Objectives:
explain how lipid composition, acyl chain length, surface charge, and cholesterol affect size and Tm of nanodiscs.
understand the correlation between Tm and remodeling efficiency of sHDL particles on endogenous HDL in human plasma.